Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
wasq7FhNqQFycLE0
Écouter
Français